Figure 2. The Kaplan-Meier survival estimates for patients with low molecular prognostic score (mPS; N = 614) and high mPS (N = 489) show that the 5-year lung cancer–specific survival rate is 96% for patients with low mPS and 81% for patients with high mPS (P < 0.001).